Everything by Chris.

Health and Healthcare

Can Karyopharm’s Myeloma Treatment Selinexor Pass Muster?

Mar 15, 2019 Retail

Why Ulta Earnings Are Beautiful

Mar 15, 2019 Technology

How a Big Bottom Line Beat Saved Broadcom

Mar 14, 2019 Technology

Oracle Slides By in Q3

Mar 14, 2019 Investing

Thursday’s Biggest Winners and Losers in the S&P 500

Mar 14, 2019 Health and Healthcare

How Much More Talc Fallout Will Johnson & Johnson Face After This $29 Million Verdict?

Mar 14, 2019 Technology

What to Watch When Broadcom Reports Earnings

Mar 14, 2019 Retail

Will It Take a Proxy Fight to Finally Turn GameStop Around?

Mar 14, 2019 Technology

What to Expect When Oracle Reports After the Close

Mar 14, 2019 Media

Facebook Staring Down US Probe of Data Deals

Mar 14, 2019 Retail

Why Dollar General Earnings Are Too Cheap for Investors

Mar 14, 2019 Investing

Wednesday’s Biggest Winners and Losers in the S&P 500

Mar 13, 2019 Media

Why Analysts Are Tuning Out on Roku

Mar 13, 2019 Retail

What to Expect When Dollar General Reports Thursday

Mar 13, 2019 Companies and Brands

Kraft Heinz Explores Breakstone’s Sale: Still Feeling Fallout From Q4?

Mar 13, 2019 Companies and Brands

Nelson Peltz Very High on Aurora Cannabis

Mar 13, 2019 Retail

Can Rite Aid Save Itself With This Restructuring?

Mar 13, 2019 Investing

Tuesday’s Biggest Winners and Losers in the S&P 500

Mar 12, 2019 Services

Will ADT Ever Get It Right?

Mar 12, 2019 Technology

Wedbush’s Apple Predictions for March 25

Mar 12, 2019